{
    "root": "348d4b09-9de2-24ef-e063-6394a90a698b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Quetiapine fumarate",
    "value": "20250507",
    "ingredients": [
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        }
    ],
    "indications": "Quetiapine is an atypical antipsychotic indicated for the treatment of: Schizophrenia ( 1.1 ) Bipolar I disorder manic episodes ( 1.2 ) Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications": "Quetiapine tablets can be taken with or without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults ( 2.2 ) 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) ( 2.2 ) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex ( 2.2 ) 50 mg twice daily 400 to  800 mg/day 800 mg/day Bipolar Mania- Children and Adolescents (10 to 17 years), Monotherapy ( 2.2 ) 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults ( 2.2 ) 50 mg once daily at bedtime 300 mg/day 300 mg/day Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions": "25 mg tablets are peach, round, biconvex, film-coated tablets, debossed with '25' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-902-83\n                  Bottles of 100 with child-resistant cap.........................NDC 47335-902-88\n                  Bottles of 1000.............................................................NDC 47335-902-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets............NDC 47335-902-61 \n  \n                       50 mg tablets are white, round, biconvex, film-coated tablets, debossed with '50' on one side and plain on the other side and are supplied as:\n \n                  Bottles of 30 with child-resistant cap...........................NDC 47335-903-83\n                  Bottles of 100 with child-resistant cap.........................NDC 47335-903-88\n                  Bottles of 1000............................................................NDC 47335-903-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets...........NDC 47335-903-61\n                  \n                  100 mg tablets are yellow, round, biconvex, film-coated tablets, debossed with '904' on one side and plain on the other side and are supplied as:\n                  Bottles of 30 with child-resistant cap...........................NDC 47335-904-83\n                  Bottles of 100 with child-resistant cap.........................NDC 47335-904-88\n                  Bottles of 1000............................................................NDC 47335-904-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets...........NDC 47335-904-61 \n  \n                       200 mg tablets are white, round, biconvex, film-coated tablets, debossed with '905' on one side and plain on the other side and are supplied as:\n \n                  Bottles of 30 with child-resistant cap...........................NDC 47335-905-83\n                  Bottles of 100 with child-resistant cap ........................NDC 47335-905-88\n                  Bottles of 1000............................................................NDC 47335-905-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets...........NDC 47335-905-61 \n  \n                       300 mg tablets are white, capsule-shaped, biconvex, film-coated tablets, debossed with '906' on one side and plain on the other side and are supplied as:\n \n                  Bottles of 30 with child-resistant cap...........................NDC 47335-906-83\n                  Bottles of 60 with child-resistant cap...........................NDC 47335-906-86\n                  Bottles of 100 with child-resistant cap.........................NDC 47335-906-88\n                  Bottles of 1000............................................................NDC 47335-906-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets...........NDC 47335-906-61 \n  \n                       400 mg tablets are yellow, capsule-shaped, biconvex, film-coated tablets, debossed with '907' on one side and plain on the other side and are supplied as:\n \n                  Bottles of 30 with child-resistant cap...........................NDC 47335-907-83\n                  Bottles of 100 with child-resistant cap.........................NDC 47335-907-88\n                  Bottles of 1000............................................................NDC 47335-907-18\n                  Unit-dose blister pack of 100 (10 × 10) tablets...........NDC 47335-907-61 \n  \n                       Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "Hypersensitivity to quetiapine or to any excipients in the quetiapine formulation. Anaphylactic reactions have been reported in patients treated with quetiapine."
}